Tang Capital
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6567153
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6567136
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6567123
http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=6561928
Company to Raise $8.1 Million to Fund NDA Stage Program REDWOOD CITY, Calif.--(BUSINESS WIRE)-- A.P. Pharma (Nasdaq: APPA), a specialty pharmaceutical company, today announced it has entered into a definitive securities purchase agreement with certain existing accredited investors providing for a private placement of up to $13.1 million in two tranches, the first consisting of common stock and warrants with aggregate proceeds of approximately $8.1 million, and a second tranche of common stock with proceeds of approximately $5 million. A.P. Pharma expects to complete the ...
-
Cell Genesys (CEGE) Reports Tender Offer Results, Continues to Pursue Strategic Alternatives
-
Penwest (PPCO) Urges Shareholders to Reject Tang Capital and Perceptive's Wind Down Proposal
-
Notable Mergers and Acquisitions of the Day 7/8 (PPG, NSTR, NUE)
-
Northstar Neuroscience (NSTR) Rejects Takeover Offer from Tang Capital
-
Notable Mergers and Acquisitions of the Day 7/3 (PENN, NSTR, CGNX)
-
Northstar Neuroscience (NSTR) Board to Review Tang Capital's Unsolicited Offer
-
Unusual 11 Mid-Day Movers 7/2: MAXY, APOL, ERII, NSTR Higher; MBRK, TTP, ALDN, DTG Lower
-
Notable Mergers and Acquisitions of the Day 7/2 (BBI/CC, NVT/NOK, NSTR)
-
Tang Capital Offers $2.25/Share for Northstar Neuroscience (NSTR)
